At issue: Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment recommendations

Schizophrenia Bulletin

Volumn 24, Issue 1, 1998, Pages 1-10

  Lehman, Anthony F ^a   Steinwachs, Donald M ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Mental health services; Quality of care

Indexed keywords

ACETOPHENAZINE; ANTIPARKINSON AGENT; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; PERPHENAZINE; PLACEBO; PROCHLORPERAZINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; TRIFLUPROMAZINE;

ANTICHOLINERGIC EFFECT; CLINICAL TRIAL; DOSE RESPONSE; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FAMILY THERAPY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MAINTENANCE THERAPY; MEDICAL PRACTICE; MENTAL HEALTH SERVICE; ORAL DRUG ADMINISTRATION; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA; VOCATIONAL REHABILITATION; ARTICLE; FINANCIAL MANAGEMENT; GOVERNMENT; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; TREATMENT OUTCOME; UNITED STATES;

COMBINED MODALITY THERAPY; HEALTH POLICY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH SUPPORT; SCHIZOPHRENIA; TREATMENT OUTCOME; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 0031614053     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033302     Document Type: Review

References (15)

1. Baldessarini, R.J.; Cohen, B.M.; and Teicher, M. Pharmacologic treatment. In: Levy, S.T., and Ninan, P.T., eds. Schizophrenia: Treatment of Acute Psychotic Episodes. Washington DC: American Psychiatric Press, 1990. pp. 61-118.
2. Buchanan, R.W. Clozapine: Efficacy and safety. Schizophrenia Bulletin, 21(4):579-591, 1995.
3. Davis, J.M.; Barter, J.T.; and Kane, J.M. Antipsychotic drugs. In: Kaplan, H.I., and Sadock, B.J., eds. Comprehensive Textbook of Psychiatry. Baltimore, MD: Williams & Wilkins, 1989. pp. 1591-1626.
4. Dixon, L.B., and Lehman, A.F. Family interventions for schizophrenia. Schizophrenia Bulletin, 21(4):631-643, 1995.
5. Dixon, L.B.; Lehman, A.F.; and Levine, J. Conventional antipsychotic medications for schizophrenia. Schizophrenia Bulletin, 21(4):567-577, 1995.
6. Johns, C.A., and Thompson, J.W. Adjunctive treatments in schizophrenia: Pharmacotherapies and electroconvulsive therapy. Schizophrenia Bulletin, 21(4):607-619, 1995.
7. Kane, J.M. Schizophrenia. New England Journal of Medicine, 334:34-41, 1996.
8. Kane, J.M., and Marder, S.R. Psychopharmacologic treatment of schizophrenia. Schizophrenia Bulletin, 19(2): 287-302, 1993.
9. Kissling, W. Ideal and reality of neuroleptic relapse prevention. British Journal of Psychiatry, 161 (Suppl.): 133-139, 1992.
10. Lehman, A.F. Vocational rehabilitation in schizophrenia. Schizophrenia Bulletin, 21(4):645-656, 1995.
11. Rifkin, A., and Siris, S. Drug treatment of acute schizophrenia. In: Meltzer, H., ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press, 1987. pp. 1095-1101.
12. Scott, J.E., and Dixon, L.B. Assertive community treatment and case management for schizophrenia. Schizophrenia Bulletin, 21(4):657-668, 1995a.
13. Scott, J.E., and Dixon, L.B. Psychological interventions for schizophrenia. Schizophrenia Bulletin, 21(4):62l-630, 1995b.
14. Umbricht, D., and Kane, J.M. Risperidone: Efficacy and safety. Schizophrenia Bulletin, 21(4):593-606, 1995.
15. Zito, J.M. Psychotherapeute Drug Manual. 3rd ed. New York, NY: John Wiley & Sons, 1994.